A Biogen employee who allegedly concealed her coronavirus symptoms on a flight back to China may face criminal charges. But first, the biotech has decided it wants nothing to do with the rogue staffer ...

A Biogen management meeting held in Boston in late February has spawned 108 confirmed or presumptive positive cases of the novel coronavirus—and has now led to a criminal investigation. Monday, ...

A statistician who was working in Massachusetts for Biogen Inc.,the sponsor of the now infamous Boston meeting at the epicenter of the state’s COVID-19 outbreak, is being investigated in Beijing for ...

BOSTON (CBS) – A Biogen employee living in Belmont is reportedly under investigation in China after flying there while she was sick. The Boston Globe reports that Jei Li did not attend the Biogen ...

A Biogen employee who allegedly flew from Massachusetts to Los Angeles to China and then tested positive for COVID-19 is under investigation in China for concealing her symptoms and putting fellow ...

A Massachusetts resident and former Biogen employee could face prison time in China after hiding COVID-19 symptoms while flying to China, according to several reports. Jie Li, 37, of Belmont, a ...

With $185 million in series A funding and an army of experienced leaders in its ranks, Braveheart Bio is setting off to joust ...

SPINRAZA is the standard of care for treating infants, children and adults with spinal muscular atrophy, a rare, genetic neuromuscular disease SPINRAZA was approved under the China National Medical ...

China’s Foreign Ministry spokesperson, Mao Ning, Tuesday referenced unspecified “countermeasures” that might be used against countries now requiring COVID-19 testing from passengers travelling from ...

Biogen (NASDAQ:BIIB) and its Japanese partner Eisai’s (OTCPK:ESALF) (OTCPK:ESAIY) breakthrough Alzheimer's therapy, Leqembi (lecanemab), is now available in China, the companies announced late ...

CAMBRIDGE, Mass., April 15, 2021 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) today announced that China’s National Medical Products Administration (NMPA) has approved TECFIDERA® (dimethyl fumarate) ...